Toshiba fills senior VP slot in U.S.
Toshiba America Medical Systems named Peter N.S. Annand tothe position of senior vice president of sales, marketing, serviceand ultrasound this month. The move provides company-wide seniormanagement support for TAMS president Kunio Sumikawa, which
Toshiba America Medical Systems named Peter N.S. Annand tothe position of senior vice president of sales, marketing, serviceand ultrasound this month. The move provides company-wide seniormanagement support for TAMS president Kunio Sumikawa, which hadbeen lacking for two years.
Annand will be the highest ranking non-Japanese in the multimodalityimaging vendor's U.S. operations, with responsibility for allmodality products. He fills the role at Tustin, CA-based TAMSthat was left vacant by the departure of Ronald B. Schilling in1991 (SCAN 1/29/92).
The executive comes to TAMS from Toshiba's Australiansubsidiary,where he was general manager of the medical division for fouryears. This division's sales grew 44% during his tenure. Annandhas 30 years' experience in the medical industry, having servedin Australia, Canada and the U.S.
In other Toshiba news, the vendor received Food and Drug Administration510(k) clearance last month for its Flexart 0.5-tesla MRI scanner.
Flexart is based on a high-speed RISC microprocessor and hasan icon-based X-Windows graphical user interface for easier operation.Flexart was introduced at last year's Radiological Society ofNorth America meeting (SCAN 11/17/93). The unit is Toshiba's premiummid-field offering.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
